India approved Oxford-AstraZeneca COVID-19 vaccine on January 1, 2021, 2 days after the UK approved the coronavirus jab.
“India approval of Oxford vaccine has come yesterday,” a highly-placed source at Central Drugs Standard Control Organisation (CDSCO) told media.
The CDSCO had first reviewed three EUA applications on December 9 and sought more information from all vaccine makers, including Serum Institute of India (SII), which is making the AstraZeneca shots.Reacting to UK approval, the Serum Institute of India (SII) also said that it is hoping for the emergency use approval of the COVID-19 vaccine ‘Covishield’ by the end of this month or January in India.
The approval paves the way for its rollout in the world’s second worst affected country
Discussion about this post